verified SJR 1,258 · Q1 • database Scopus / SJR & Web of Science indexed

United Kingdom · Elsevier Ltd

workspace_premium Q1 — Oncology lock Subscription

Cancer Epidemiology

Cancer Epidemiology is a journal indexed in SJR in Oncology and Epidemiology with an H index of 90. It has an SJR impact factor of 1,258 and it has a best quartile of Q1. It has an SJR impact factor of 1,258.

Cancer Epidemiology focuses its scope in these topics and keywords: cancer, risk, cervical, screening, casecontrol, samples, supplementation, studyvariation, selfcollected, switzerlandcan, ...

ISSN: 1877-7821

Publisher: Elsevier Ltd

Category: Oncology

Indexation: verifiedScopus / SJR verifiedWeb of Science

open_in_new Portal NPD menu_book Guidelines NPD

schedule CountryOfPapers database fields

SJR Impact Factor trending_up

1,258 Q1

H-index 90

Acceptance rate pie_chart

26% Selective

Source Acceptance_Rate

Time to publication hourglass_top

NPD

Field NPD

Publication cost (APC) payments

NPD Subscription

Non-OA path NPD

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science

SJR Impact

1,258

H-index

Docs (year)

158

Docs 3y

468

Total refs

6074

Cites 3y

1312

Citable 3y

454

Cites/Doc 2y

2.39

Ref/Doc

38.44

Immediate OA

—

Embargoed OA

NPD

Non OA / Submission

—

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Clinical features predicting identification of CDKN2A mutations in Italian patients with familial cutaneous melanoma

Which women with breast cancer do, and do not, undergo receptor status testing? A population-based study

Evaluation of breast cancer risk associated with tea consumption by menopausal and estrogen receptor status among Chinese women in Hong Kong

Epidemiology of malignant peritoneal mesothelioma: A population-based study

Environmental heavy metal as a potential risk factor for the progression of oral potentially malignant disorders in central Taiwan

Effect of hENT1 polymorphism G-706C on clinical outcomes of gemcitabine-containing chemotherapy for Chinese non-small-cell lung cancer patients

Duration of ovarian hormone exposure and gynecological cancer risk in Korean women: the Korean Heart Study

Does night work increase the risk of breast cancer? A systematic review and meta-analysis of epidemiological studies

Data quality at the Bulgarian National Cancer Registry: An overview of comparability, completeness, validity and timeliness

Cyclin D1 gene polymorphism, A870G, is associated with an increased risk of salivary gland tumors in the Chinese population

Comparison of cumulative false-positive risk of screening mammography in the United States and Denmark

Comparability, diagnostic validity and completeness of Nigerian cancer registries

SHOW MORE ARTICLES

Colorectal cancer metastatic disease progression in Australia: A population-based analysis

A comparison of prostate cancer survival in England, Norway and Sweden: A population-based study

Black:White disparities in lung cancer mortality in the 50 largest cities in the United States

Bayesian prediction of lung and breast cancer mortality among women in Spain (2014-2020)

Asthma, allergy and the risk of prostate cancer: Results from the Montreal PROtEuS study

Association of physical activity and polymorphisms in FGFR2 and DNA methylation related genes with breast cancer risk

Association between the neighborhood obesogenic environment and colorectal cancer risk in the Multiethnic Cohort

Aspirin, nonaspirin nonsteroidal anti-inflammatory drugs, acetaminophen and ovarian cancer survival

An epidemiological evaluation of salivary gland cancer in the Netherlands (1989-2010)

A retrospective analysis to determine factors contributing to the survival of patients with oral squamous cell carcinoma

A remark about CYP1A1 Thr461Asn genotype frequencies in a recent endometrial cancer case-control study

A missense variant in PTPN12 associated with the risk of colorectal cancer by modifying Ras/MEK/ERK signaling

FAQs

Cancer Epidemiology has an SJR of 1,258 (best quartile Q1) in the CountryOfPapers database.

Immediate OA APC is not available (NPD).

The acceptance rate recorded for Cancer Epidemiology is 26%.

Cancer Epidemiology

Metrics

Name good journals. Call out predatory ones.

Researcher reviews

Best articles by citations

FAQs

What is the SJR of Cancer Epidemiology?

What is the APC / publication cost?

What is the acceptance rate?